Cushman & Wakefield CFO Departs, New CFO Appointed
Ticker: CWK · Form: 8-K · Filed: Jun 11, 2024 · CIK: 1628369
Sentiment: neutral
Topics: executive-change, cfo, severance
TL;DR
CFO out, new CFO in at C&W. MacKay gets $1.5M severance.
AI Summary
Cushman & Wakefield plc announced on June 7, 2024, the departure of its Chief Financial Officer, Michelle MacKay, effective June 10, 2024. The company also appointed Alex Clavel as the new Chief Financial Officer, effective June 11, 2024. MacKay will receive a severance payment of $1,500,000, along with other benefits.
Why It Matters
A change in CFO can signal shifts in financial strategy or performance, impacting investor confidence and the company's stock price.
Risk Assessment
Risk Level: medium — Changes in key executive positions, especially the CFO, can introduce uncertainty regarding future financial strategy and performance.
Key Numbers
- $1,500,000 — Severance Payment (Amount to be paid to departing CFO Michelle MacKay.)
Key Players & Entities
- Cushman & Wakefield plc (company) — Registrant
- Michelle MacKay (person) — Departing Chief Financial Officer
- June 10, 2024 (date) — Effective date of departure
- Alex Clavel (person) — Appointed Chief Financial Officer
- June 11, 2024 (date) — Effective date of appointment
- $1,500,000 (dollar_amount) — Severance payment to Michelle MacKay
FAQ
Who is the new Chief Financial Officer of Cushman & Wakefield plc?
Alex Clavel has been appointed as the new Chief Financial Officer, effective June 11, 2024.
When is Michelle MacKay's departure effective?
Michelle MacKay's departure as Chief Financial Officer is effective June 10, 2024.
What is the severance package for Michelle MacKay?
Michelle MacKay will receive a severance payment of $1,500,000, along with other benefits.
What is the effective date for the new CFO's role?
Alex Clavel's appointment as Chief Financial Officer is effective June 11, 2024.
What is the primary reason cited for Michelle MacKay's departure?
The filing states Michelle MacKay is departing from her role as Chief Financial Officer, but does not specify a reason beyond the change in officer.
Filing Stats: 594 words · 2 min read · ~2 pages · Grade level 12.6 · Accepted 2024-06-11 16:06:00
Key Financial Figures
- $0.10 — on which registered Ordinary shares, $0.10 nominal value CWK New York Stock Ex
Filing Documents
- d841609d8k.htm (8-K) — 22KB
- 0001193125-24-159110.txt ( ) — 138KB
- cwk-20240607.xsd (EX-101.SCH) — 3KB
- cwk-20240607_lab.xml (EX-101.LAB) — 17KB
- cwk-20240607_pre.xml (EX-101.PRE) — 11KB
- d841609d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 11, 2024 CUSHMAN & WAKEFIELD PLC By: /s/ Noelle J. Perkins Name: Noelle J. Perkins Title: Executive Vice President, General Counsel and Corporate Secretary